Status:
UNKNOWN
THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS
Lead Sponsor:
University of Campinas, Brazil
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Head and neck cancer corresponds to tumors located in the upper aerodigestive tract, such as the oral cavity, pharynx and larynx. The most effective treatment consists of high dose of cisplatin chemot...
Eligibility Criteria
Inclusion
- head and neck cancer
- anticancer treatment - cisplatin (80 to 100 mg/m²) plus radiotherapy
- patients without previous treatment of head and neck cancer (surgery, chemotherapy and radiotherapy)
Exclusion
- severe psychiatric diseases
- impossibility of verbal communication
- without caregivers or companions
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02241876
Start Date
October 1 2014
Last Update
September 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of Campinas - UNICAMP, Hospital das Clinicas
Campinas, São Paulo, Brazil, 13083-888